We are live on ! Find out more
TPTX

Turning Point Therapeutics, Inc. Common Stock
TPTX

Delisted

TPTX was delisted on the 16th of August, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Turning Point Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 208 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 208 → 0 (-208)

100% less funds holding in top 10

Funds holding in top 10: 10 → 0 (-10)

100% less capital invested

Capital invested by funds: $3.06B → $0 (-$3.06B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 208

Holders
–
Holders Change
-208
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
208
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$313M
2
BlackRock
BlackRock
New York
-$285M
3
CAM
Cormorant Asset Management
Massachusetts
-$187M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$144M
5
State Street
State Street
Massachusetts
-$124M
Name Holding Trade Value Shares
Change 		Change in
Stake
Prudential Financial
126
Prudential Financial
New Jersey
– -$998K -13,266 Closed
MTCM
127
Mint Tower Capital Management
Netherlands
– -$963K -12,796 Closed
SO
128
STRS Ohio
Ohio
– -$910K -12,100 Closed
ASRS
129
Arizona State Retirement System
Arizona
– -$908K -12,068 Closed
SC
130
Sarissa Consulting
California
– -$903K -12,000 Closed
BNP Paribas Financial Markets
131
BNP Paribas Financial Markets
France
– -$855K -11,367 Closed
AG
132
Algert Global
California
– -$855K -11,357 Closed
Skandinaviska Enskilda Banken (SEB)
133
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$753K -10,000 Closed
Jane Street
134
Jane Street
New York
– -$749K -9,959 Closed
CIP
135
Chartwell Investment Partners
Pennsylvania
– -$736K -9,784 Closed
ProShare Advisors
136
ProShare Advisors
Maryland
– -$677K -9,009 Closed
Squarepoint
137
Squarepoint
New York
– -$662K -8,797 Closed
MCI
138
McDonald Capital Investors
California
– -$649K -8,625 Closed
Wells Fargo
139
Wells Fargo
California
– -$645K -8,569 Closed
Principal Financial Group
140
Principal Financial Group
Iowa
– -$640K -8,506 Closed
Janus Henderson Group
141
Janus Henderson Group
United Kingdom
– -$629K -8,351 Closed
BC
142
Birchview Capital
Vermont
– -$602K -8,000 Closed
Nisa Investment Advisors
143
Nisa Investment Advisors
Missouri
– -$575K -7,638 Closed
Handelsbanken Fonder
144
Handelsbanken Fonder
Sweden
– -$557K -7,400 Closed
Renaissance Technologies
145
Renaissance Technologies
New York
– -$557K -7,400 Closed
SC
146
Sagefield Capital
Texas
– -$527K -7,000 Closed
YIH
147
Y-Intercept (HK)
Hong Kong
– -$521K -6,928 Closed
Teacher Retirement System of Texas
148
Teacher Retirement System of Texas
Texas
– -$508K -6,749 Closed
Zurich Cantonal Bank
149
Zurich Cantonal Bank
Switzerland
– -$470K -6,245 Closed
Victory Capital Management
150
Victory Capital Management
Texas
– -$452K -6,002 Closed
4 5
6
7 8

TPTX Hedge Fund Activity: Q3 2022 in Review

0 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Turning Point Therapeutics, Inc. Common Stock (TPTX) for Q3 2022, worth a combined $0 — down 100% from $3.06B a quarter earlier.

Sellers outnumbered buyers: 208 funds closed out of TPTX and 0 opened new positions — a net loss of 208 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $313M sold.

  • 0 institutional investors held Turning Point Therapeutics, Inc. Common Stock (TPTX) as of Q3 2022, down from 208 in Q2 2022.
  • Funds reported $0 of Turning Point Therapeutics, Inc. Common Stock stock for Q3 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Turning Point Therapeutics, Inc. Common Stock positions in Q3 2022 and 208 closed out, a net change of -208 holders.
  • The largest Turning Point Therapeutics, Inc. Common Stock seller in Q3 2022 was Vanguard Group, an estimated $313M sold.

Based on aggregated 13F filings for Q3 2022.